Pruritus Therapeutics: A Leading Driver Behind Surge In Dermatological Disorders Fuels Pruritus Therapeutics Market Growth Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Pruritus Therapeutics Industry Market Size Be by 2025?
The market size of pruritus therapeutics has been witnessing a steady surge in the past few years. It is projected to escalate from $11.89 billion in 2024 to $12.38 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.1%. The increase during the historical timeline could be traced back to the escalating cases of pruritus, varied causes and circumstances, the rise in the elderly population, and an emphasis on patient quality of life.

What's the Long-Term Growth Forecast for the Pruritus Therapeutics Market Size Through 2029?
The market size for pruritus therapeutics is set to experience significant growth in the upcoming years, with projections indicating a rise to $15.7 billion by 2029, at a 6.1% compound annual growth rate. This anticipated growth across the forecasted timeline can be accredited to several factors. This includes a widening understanding of pruritus pathophysiology, advancements in drug formulation and distribution, an emphasis on personalized medicine, an uptick in dermatological research and development, an increase in recognition and diagnosis rates, and a heightened interest in plant-based and herbal treatments. Key trends during the forecast period encompass the progression of itch-specific receptor agonists and antagonists, a market focus on individualized therapeutic strategies, the incorporation of technology in itch tracking and management, and partnerships for interdisciplinary research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

What Are the Key Growth Drivers Fueling the Pruritus Therapeutics Market Expansion?
The escalating occurrence of dermatological conditions is anticipated to fuel the expansion of the pruritus therapeutics market. Dermatological conditions involve issues related to skin, hair, nail, and mucous membrane ranging from ailments such as acne and eczema to more serious concerns like skin cancer and fungal infections. The root cause of itching typically dictates the application of pruritus treatments for these skin-related diseases, often utilizing topical treatments, smoothing agents and moisturizers, drugs that suppress the immune response, and anti-itching medicines. To illustrate, the American Cancer Society, a US-based charitable organization committed to cancer eradication, projected that in January 2024 there will be 108,270 diagnosed cases of skin cancer. This signifies a 3.2% rise from the 104,930 cases reported in 2023. Consequently, the increasing prevalence of dermatological disorders is boosting the growth of the pruritus therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11907&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Pruritus Therapeutics Market?
Leading firms in the pruritus therapeutics market are concentrating their efforts on creating targeted treatments for unique diseases and certain patient groups, such as the non-systemic ileal bile acid transport inhibitor, a tailored therapy addressing unfulfilled medical requirements. This specific medication deals with bile acid absorption in the intestine, virtually eliminating impact on the systemic circulation and thus reducing potential adverse effects. For example, in June 2023, the US Food and Drug Administration, an agency of the Department of Health and Human Services, granted approval to Ipsen, a pharmaceutical company based in France, for their drug Bylvay (odevixibat) to treat cholestatic pruritus in patients twelve months and older suffering from Alagille syndrome (ALGS). Bylvay, a once-daily, non-systemic ileal bile acid transport inhibitor, boasts minimal systemic exposure and is the first drug of this nature approved for cholestatic pruritus resulting from progressive familial intrahepatic cholestasis (PFIC) in the U.S. It had previously been approved for PFIC treatment in Europe, and is currently available by prescription to qualifying ALGS patients.

How Is the Pruritus Therapeutics Market Segmented?
The pruritus therapeutics market covered in this report is segmented -

1) By Product: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressants, Calcineurin Inhibitors, Other Products
2) By Route Of Administration: Oral, Parenteral, Topical
3) By Disease Type: Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
4) By End-User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Topical Immunosuppressants, Systemic Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream
7) By Other Products: Moisturizers And Emollients, Antipruritic Herbal Remedies, Combination Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11907&type=smp

Which Companies Are Leading the Charge in Pruritus Therapeutics Market Innovation?
Major companies operating in the pruritus therapeutics market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc. , Bausch Health Companies Inc., Galderma Laboratories LP, Cipla Limited, LEO Pharma AS, Cara Therapeutics Inc., GlaxoSmithKline Plc, Novan Inc., Escient Pharmaceuticals Inc., Nerre Therapeutic Ltd., EPI Health LLC, Trevi Therapeutics Inc., Evelo Biosciences, Toray Medical Co. Ltd.

Which Regions Are Leading the Global Pruritus Therapeutics Market in Revenue?
North America was the largest region in the pruritus treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pruritus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11907

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.